OneSource in talks to raise Rs 1,670 crore in pre-listing round

OneSource, a TPG Growth-backed specialty pharma CDMO, is in talks with investors to raise $200 million. The company, formerly Stelis Biopharma, was demerged from Strides Pharma and aims to list on BSE and NSE within a year. OneSource plans to reduce debt and expand its manufacturing capabilities.